WorldPharmaNews
Search ...
Home
Business
Research
Events
Regulatory
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
www.gsk.com
List of articles in category GlaxoSmithKline
Title
Published Date
GlaxoSmithKline announces start of two phase III studies in advanced/metastatic melanoma
24 January 2011
GlaxoSmithKline announces Q4 2010 legal charge
17 January 2011
GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK'786
13 January 2011
GSK responds to 60 Minutes | Related Video
03 January 2011
GSK to acquire Nanjing MeiRui Pharmaceuticals in China
09 December 2010
GlaxoSmithKline to increase its shareholding in Theravance
29 November 2010
GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia
28 November 2010
GlaxoSmithKline receives approval in Japan for two medicines: Revolade and Xyzal
31 October 2010
GSK outlines approach to delivering advances in the treatment of rare diseases
19 October 2010
GSK increases support for WHO strategy to improve children's health
18 October 2010
Start
Prev
9
10
11
12
13
14
15
16
17
18
Next
End
Business & Industry
Pfizer reports record full-year 2022 results
AMJEVITA™ (adalimumab-atto), first biosimilar to Humira® now available in the United States
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
Research & Development
Scientists pinpoint protein that helps cancer-causing viruses evade immune response
Transforming the way cancer vaccines are designed and made
Antidepressants used for chronic pain on the rise, but are they effective?
Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
Power of cancer drugs may see boost by targeting newly ID'd pathway
Conferences & Events
SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
SAE Media Group's 6th annual 3D Cell Culture Conference
CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
CPHI Excellence in Pharma Award Winners 2022
CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
FDA grants Accelerated Approval for Alzheimer's disease treatment
FDA approves new HIV drug for adults with limited treatment options
FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
FDA approves first gene therapy to treat adults with Hemophilia B
FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
You are here:
Home
GlaxoSmithKline
SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate